Jazz Pharmaceuticals (JAZZ) PT Lowered to $190 at B.Riley/FBR
Get Alerts JAZZ Hot Sheet
Price: $120.42 -0.07%
Rating Summary:
31 Buy, 6 Hold, 0 Sell
Rating Trend: Up
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 0
Rating Summary:
31 Buy, 6 Hold, 0 Sell
Rating Trend: Up
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 0
Join SI Premium – FREE
B.Riley/FBR analyst David Buck lowered the price target on Jazz Pharmaceuticals (NASDAQ: JAZZ) to $190.00 (from $219.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jazz Pharmaceuticals (JAZZ) PT Raised to $190 at JPMorgan
- Hyundai Motor (005380:KS) (HYMTF) PT Raised to KRW290 at Citi
- MAG Silver (MAG:CN) (MAG) PT Raised to Cdn$19.50 at Stifel Canada
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
David BuckSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!